Clinical Trial Update: Role of Urinary Sphingosine 1-Phosphate as a Biomarker for Detrusor Hyperactivity in Multiple Sclerosis

View source ↗

Summary

This clinical trial investigates urinary sphingosine-1-phosphate as a biomarker for detrusor hyperactivity in people with multiple sclerosis. The study is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Multiple Sclerosis | Status: RECRUITING